日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Next-generation sequencing reveals clinically actionable molecular markers in myeloid sarcoma

新一代测序揭示了髓系肉瘤中具有临床应用价值的分子标志物

Li, Z; Stölzel, F; Onel, K; Sukhanova, M; Mirza, M K; Yap, K L; Borinets, O; Larson, R A; Stock, W; Sasaki, M M; Joseph, L; Raca, G

Quantitative characterization of T-cell repertoire in allogeneic hematopoietic stem cell transplant recipients

同种异体造血干细胞移植受者T细胞库的定量表征

Yew, P Y; Alachkar, H; Yamaguchi, R; Kiyotani, K; Fang, H; Yap, K L; Liu, H T; Wickrema, A; Artz, A; van Besien, K; Imoto, S; Miyano, S; Bishop, M R; Stock, W; Nakamura, Y

NAC1 modulates sensitivity of ovarian cancer cells to cisplatin by altering the HMGB1-mediated autophagic response

NAC1通过改变HMGB1介导的自噬反应来调节卵巢癌细胞对顺铂的敏感性

Zhang, Y; Cheng, Y; Ren, X; Zhang, L; Yap, K L; Wu, H; Patel, R; Liu, D; Qin, Z-H; Shih, I-M; Yang, J-M

NAC-1, a potential stem cell pluripotency factor, contributes to paclitaxel resistance in ovarian cancer through inactivating Gadd45 pathway.

NAC-1 是一种潜在的干细胞多能性因子,它通过使 Gadd45 通路失活,导致卵巢癌对紫杉醇产生耐药性

Jinawath N, Vasoontara C, Yap K-L, Thiaville M M, Nakayama K, Wang T-L, Shih I-M